Citation Impact
Citing Papers
A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation
2002 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23
2012 Standout
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
2008 Standout
Intensive versus Conventional Glucose Control in Critically Ill Patients
2009 Standout
The Effect of Selenium Supplementation in the Prevention of DNA Damage in White Blood Cells of Hemodialyzed Patients: A Pilot Study
2010
Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT
1997
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
2005 Standout
Heart-Rate Profile during Exercise as a Predictor of Sudden Death
2005 Standout
Long-Term Trends in the Incidence of and Survival with Heart Failure
2002 Standout
Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1
2007 StandoutNobel
Clinical trials of arrhythmia management: Methods or madness
1996
Pulmonary Effect of Amiodarone in Patients With Heart Failure
1997
Ventricular Arrhythmias in Adult Aortic Stenosis
1998
The Quality of Health Care Delivered to Adults in the United States
2003 Standout
Selenium Supplementation on Plasma Glutathione Peroxidase Activity in Patients with End-Stage Chronic Renal Failure
2004
A comparison of three different sources of data in assessing the frequencies of adverse reactions to amiodarone
2004
Insulin‐based regimens decrease mortality rates in critically ill patients: a systematic review
2006
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation
2002
Selenium and human health
2012 Standout
Metabolic manipulation in ischaemic heart disease, a novel approach to treatment
2004
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Thyroid Hormone and the Cardiovascular System
2001 Standout
Selenium and coronary heart disease: a meta-analysis
2006
Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia
1995
Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required?
1998
Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials
2009
Implantable cardioverter-defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias
1996
A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
1999 Standout
Selenium Concentrations and Glutathione Peroxidase Activities in Blood of Patients Before and After Allogenic Kidney Transplantation
2004
Antiarrhythmic Therapies for the Prevention of Sudden Cardiac Death
1997
Trends in Heart Failure Incidence and Survival in a Community-Based Population
2004 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
1996 Standout
Antioxidant Activity of Sulfur and Selenium: A Review of Reactive Oxygen Species Scavenging, Glutathione Peroxidase, and Metal-Binding Antioxidant Mechanisms
2009
Randomised trial of low-dose amiodarone in severe congestive heart failure
1994
Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction
1996
Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction
2003
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
Chronic kidney disease: global dimension and perspectives
2013 Standout
A Comparison of Seven Antiarrhythmic Drugs in Patients with Ventricular Tachyarrhythmias
1993
Worldwide access to treatment for end-stage kidney disease: a systematic review
2015 Standout
Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT
1997
A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation
2002 Standout
Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury*
2006
Oxidative stress in chronic kidney disease
2018 Standout
Task Force on Sudden Cardiac Death of the European Society of Cardiology
2001
Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
2009
Improving survival for patients with advanced heart failure: A study of 737 consecutive patients
1995
Myocardial Reperfusion Injury
2007 Standout
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
1997 Standout
Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction*
2010
Effect of Spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy
2000
Demography of paediatric renal care in Europe: organization and delivery
2004
Adjunctive Drug Therapy of Acute Myocardial Infarction — Evidence from Clinical Trials
1996
The Management of Hypertrophic Cardiomyopathy
1997
Prevalence and natural history of adrenal incidentalomas
2003
Reperfusion injury in humans: A review of clinical trials on reperfusion injury inhibitory strategies
2007
Moderate and severe traumatic brain injury in adults
2008 Standout
Proarrhythmia with Class III Antiarrhythmic Drugs: Definition, Electrophysiologic Mechanisms, Incidence, Predisposing Factors, and Clinical Implications
1995
Sympathetic activation, ventricular repolarization and Ikrblockade: Implications for the antifibrillatory efficacy of potassium channel blocking agents
1995
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Selenium and Selenium-Dependent Antioxidants in Chronic Kidney Disease
2015
Expert consensus document on arterial stiffness: methodological issues and clinical applications
2006 Standout
The SWORD of Damocles
1996
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
2005 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Estimation of Oxidative Stress Markers in Chronic Kidney Disease
2010
Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion Injury
2009
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
2011 Standout
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Availability of renal replacement therapy in Central and Eastern Europe.
2009
A Decade of Clinical Trial Developments in Postmyocardial Infarction, Congestive Heart Failure, and Sustained Ventricular Tachyarrhythmia Patients: From CAST to AVID and Beyond
1998
Changes in Arterial Structure and Function Under Trandolapril-Verapamil Combination in Hypertension
1999
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias
1997 Standout
Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases
2002 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure
1998 Standout
Insulin Therapy for Critically Ill Hospitalized Patients
2004
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2010 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Effect of Glucose-Insulin-Potassium Infusion on Mortality in Patients With Acute ST-Segment Elevation Myocardial Infarction
2005
Sudden Cardiac Death
1998 Standout
Metabolic Modulation of Acute Myocardial Infarction
1998
Oxidative stress in chronic kidney disease.
2015
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study)
1993
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Canadian Implantable Defibrillator Study (CIDS): Study design and organization
1993
The Effects of Amiodarone on the Thyroid*
2001
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of E Nartowicz being referenced
Low-Dose Glucose-Insulin-Potassium Is Ineffective in Acute Myocardial Infarction: Results of a Randomized Multicenter Pol-GIK Trial
1999
Selenium, glutathione peroxidases, and some other antioxidant parameters in blood of patients with chronic renal failure
2001
Selenium and glutathione levels, and glutathione peroxidase activities in blood components of uremic patients on hemodialysis supplemented with selenium and treated with erythropoietin
2001
Effect of amiodarone on mortality after myocardial infarction: A double-blind, placebo-controlled, pilot study
1992
Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction
1999
PARATHORMON, CALCIUM, PHOSPHORUS, AND LEFT VENTRICULAR STRUCTURE AND FUNCTION IN NORMOTENSIVE HEMODIALYSIS PATIENTS
2001
Effect of Erythropoietin Therapy and Selenium Supplementation on Some Antioxidant Parameters in Blood of Uremic Patients on Long-Term Hemodialysis
2002
Renal replacement therapy in an era of socioeconomic changes - report from the Polish registry
1997
[Adrenal cortical adenomas and hypertension].
1967
Increased Plasma Glutathione Peroxidase Activity in Patients with Acute Myocardial Infarction
2002